Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
08/2001
08/23/2001DE19960683A1 Substituierte 2,4-Diamino-1,3,5-triazine, Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren Substituted 2,4-diamino-1,3,5-triazines, to processes for preparation and use as herbicides and plant growth regulators
08/23/2001DE10007286A1 New phenyl-substituted heterocyclic enaminone and enaminethione derivatives useful as herbicides and pesticides, especially insecticides, acaricides, nematocides and fungicides
08/23/2001CA2651825A1 Substituted arylpyrazines
08/23/2001CA2400631A1 Beta-alanine derivatives and their use as receptor antagonists
08/23/2001CA2399147A1 4-imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use as alpha-1a agonists
08/23/2001CA2398937A1 Substituted arylpyrazines
08/22/2001EP1125931A1 Biocidal alkyl-substituted-(hetero)aryl-ketoxime-O-ethers and the production method thereof
08/22/2001EP1124824A1 Chromenone and chromanone derivatives as integrin inhibitors
08/22/2001EP1124823A1 Thrombin inhibitors
08/22/2001EP1124822A1 Thrombin inhibitors
08/22/2001EP1124821A1 Compounds
08/22/2001EP1124804A1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors
08/22/2001EP1124560A1 Use of antifungal agents for treating scleroses
08/22/2001EP1124528A1 Multivalent macrolide antibiotics
08/22/2001EP0892799B1 Quinazoline derivatives
08/22/2001EP0785926B1 Carboxylic acid derivatives, their preparation and their use as medicaments
08/22/2001EP0777653B1 Dihygropyridine derivatives as bradykinin antagonists
08/22/2001EP0752854B1 Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments
08/22/2001CN1309656A Thioalkyl alpha-substd. pyrimidine compounds
08/22/2001CN1309655A Cyclic compounds useful in treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process
08/22/2001CN1309648A Piperazinone derivs. and their uses
08/22/2001CN1309639A Pharmaceutical compositions comprising 2-quinolones
08/22/2001CN1309634A Hydrazine derivs.
08/22/2001CN1309557A Formulation contg. paroxetine
08/22/2001CN1309127A Piperazidine deriv. and preparing method thereof
08/21/2001US6277998 Reacting 2-cyano-4-oxo-4h-benzopyran compound with hydrogen sulfide and then reacting proudct with alkyl halide; reacting the product with hydrazine or its salt and then with nitrous acid compound to obtain tetrazole compound
08/21/2001US6277997 Hydrogenating asymmetrically 2,5-dihydrofuran derivative in presence of catalyst comprising metal diphosphine complex to produce lactone derivative
08/21/2001US6277885 Inhibitors of tumor necrosis factor-alpha converting enzyme
08/21/2001US6277878 Substituted indole compounds as anti-inflammatory and analgesic agents
08/21/2001US6277877 Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors
08/21/2001US6277871 Inhibitors of protein isoprenyl transferases
08/21/2001US6277859 Highly selective kappa-opioid agonists useful as analgesics and diuretics with reduced physiological side effects
08/21/2001US6277848 Systemic pesticides for controlling arthropod, nematode, helminth or protozoan pests in agriculture
08/21/2001US6277790 Substituted herbicide tetrazolinonecarboxylic acid amides
08/21/2001CA2083606C Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
08/21/2001CA2060652C N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives
08/21/2001CA2026143C Triazole compounds, their production and use
08/16/2001WO2001058899A1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
08/16/2001WO2001058895A1 Benzofuran carboxamides and their therapeutic use
08/16/2001WO2001058894A1 Stereoselective synthesis of nucleoside analogues
08/16/2001WO2001058891A2 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage
08/16/2001WO2001058881A1 Pyrimidine derivatives as selective inhibitors of cox-2
08/16/2001WO2001058875A2 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
08/16/2001WO2001058873A1 Method for producing 5-aryl nicotinaldehydes
08/16/2001WO2001058869A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
08/16/2001WO2001010842A3 Melanocortin-4 receptor binding compounds and methods of use thereof
08/16/2001WO2001010381A3 Methods for treating or preventing pain and anxiety
08/16/2001WO2001010380A3 Benzanilides as potassium channel openers
08/16/2001WO2001009119A3 Chemokine receptor antagonists
08/16/2001WO2001009096A3 Potassium channel openers
08/16/2001WO2000039104A9 Phenazine compounds, methods and pharmaceutical compositions for inhibiting parp
08/16/2001WO2000015212A3 Antifungal activity of dicationic molecules
08/16/2001US20010014694 Hypotensive agents, stroke, vision defects, kidney disorders
08/16/2001US20010014688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
08/16/2001US20010014683 Analgesics; side effect reduction
08/16/2001US20010014681 Compounds useful for inhibition of farnesyl protein transferase
08/16/2001US20010014677 Restenosis, kidney diseases, lung diseases
08/16/2001EP1123933A1 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chromane as CNS active agent
08/16/2001EP1123931A1 Tricylic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
08/16/2001EP1123925A1 Process for preparation of substituted pyridines
08/16/2001EP1123924A1 Substituted pyridines as HMG-COA reductase inhibitors
08/16/2001EP1123918A1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same
08/16/2001EP1123289A1 Oxobenzofuranylide-dihydroindolone
08/16/2001EP1123285A1 Substituted benzopyran analogs for the treatment of inflammation
08/16/2001EP1123272A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
08/16/2001EP0891345B1 Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof
08/16/2001CA2416343A1 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives
08/16/2001CA2399791A1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
08/16/2001CA2398822A1 Piperazine and piperidine derivatives
08/15/2001CN1308631A Heterocyclic derivatives which inhibit factor xa
08/15/2001CN1308622A Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
08/15/2001CN1308616A Non-peptidyl inhibitors and VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory disease
08/15/2001CN1308615A Substituted acylamino phenyl uracils
08/15/2001CN1308542A Sucoinamide inhibitors of interleukin-1& beta, converting enzyme
08/15/2001CN1308523A Pellets having a core coated with a lipid lowering agent and a polymer
08/15/2001CN1308521A Novel formulation containing paroxetine
08/14/2001US6274737 Endothelin receptor antagonists
08/14/2001US6274736 Chromatographic enantiomer separation of lactones
08/14/2001US6274613 Cyclic imines as pesticides
08/14/2001US6274610 Applying compounds such as 2-(1-chloro-cyclopropyl)-1-(2-chlorophenyl)-3-(5-(n-methyl-car bamoylthio)-1,2,4-triazol-1-yl)-propanol-2-ol to crops to prevent the growth of undesirable microorganisms
08/14/2001US6274600 Heteroatom substituted benzoyl derivatives that enhance synaptic responses mediated by AMPA receptors
08/14/2001US6274589 L-β-dioxolane uridine analogs and their pharmaceutical compositions
08/14/2001US6274536 Pyrazole derivatives as herbicides
08/14/2001US6274336 Producing three-dimensional structure of active site using computer program, displaying and superimposing three-dimensional representation of test compound onto active site, preparing test compound, and testing in biological assay
08/14/2001CA2187591C Novel tertiary heterocyclic amines; process for preparing them and pharmaceutical compositions containing them
08/09/2001WO2001057264A2 Electron-deficient nitrogen heterocycle-substituted fluorescein dyes
08/09/2001WO2001057037A1 Platelet adp receptor inhibitors
08/09/2001WO2001057033A1 C10 carbamoyloxy substituted taxanes as antitumor agents
08/09/2001WO2001057032A1 C10 ester substituted taxanes as antitumor agents
08/09/2001WO2001057031A1 C10 carbonate substituted taxanes as antitumor agents
08/09/2001WO2001057030A1 C7 carbonate substituted taxanes as antitumor agents
08/09/2001WO2001057029A1 C7 heterosubstituted acetate taxanes as antitumor agents
08/09/2001WO2001057028A1 C7 carbamoyloxy substituted taxanes as antitumor agents
08/09/2001WO2001057027A1 C7 ester substituted taxanes as antitumor agents
08/09/2001WO2001057025A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
08/09/2001WO2001057024A1 Blockade of voltage dependent sodium channels
08/09/2001WO2001057022A2 Pyrazole compositions useful as inhibitors of erk
08/09/2001WO2001057013A1 Taxane formulations having improved solubility
08/09/2001WO2001056996A1 Hydantoin c-proteinase inhibitors
08/09/2001WO2001056993A2 Pyrazole compositions useful as inhibitors of erk